3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with methylphenidate in 1 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (methylphenidate) | Trials (methylphenidate) | Recent Studies (post-2010) (methylphenidate) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 7,783 | 1,698 | 2,693 |
| Protein | Taxonomy | 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (IC50) | methylphenidate (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.061 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.1 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, J; Korn, P; Linszen, DH; van Royen, EA | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and methylphenidate
| Article | Year |
|---|---|
Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography.
Topics: Adult; Behavior; Benzamides; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Iodine Radioisotopes; Male; Methylphenidate; Pyrrolidines; Tomography, Emission-Computed, Single-Photon | 1997 |